Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$255,351,596
+$16,759,823 QoQ
Shares Held
1,005,440
+3.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#22
of 2,126 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD Waterhouse Canada Inc. holds $797,907,309 across 17 Drug Manufacturers - General names. JNJ ranks #1 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,005,440 | $255,351,596 | |
| 2 | LLY |
ELI LILLY & Co
|
192,333 | $230,689,989 | |
| 3 | ABBV |
AbbVie Inc.
|
366,299 | $92,175,480 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
482,201 | $60,921,274 | |
| 5 | MRK |
Merck & Co., Inc.
|
354,395 | $45,539,757 | |
| 6 | AMGN |
Amgen Inc
|
103,282 | $37,400,477 | |
| 7 | AZN |
Astrazeneca PLC
|
137,551 | $26,082,420 | |
| 8 | PFE |
Pfizer Inc
|
673,108 | $16,208,440 |
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $255,351,596 | 1,005,440 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $238,591,773 | 976,075 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $89,938,814 | 434,592 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $74,864,066 | 403,754 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $61,217,770 | 400,771 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $68,631,391 | 413,841 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $77,097,355 | 533,103 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $109,134,931 | 673,423 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $94,532,341 | 646,773 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $102,763,229 | 649,619 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $99,602,470 | 635,463 | Shares | Defined | 2024-05-10 | |
| 2023-09-30 | $104,188,183 | 668,945 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $112,257,981 | 678,214 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 | $94,200,630 | 607,746 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $108,478,645 | 614,088 | Shares | Defined | 2023-11-13 | |
| 2022-09-30 | $85,273,429 | 521,997 | Shares | Defined | 2023-11-13 | |
| 2022-06-30 | $89,946,092 | 506,710 | Shares | Defined | 2023-11-13 | |
| 2022-03-31 | $88,898,745 | 501,601 | Shares | Defined | 2023-11-13 | |
| 2021-12-31 | $88,689,701 | 518,441 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||